SCHEMBL1787478

SCHEMBL1787478

CCOc1ccc(OCC)c(O[C]=O)c1

nearest known ligand 0.50

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KDM4E B2RXH2 2/20 0.50
NQO1 P15559 1/20 0.45
TSHR P16473 3/20 0.42
EPHX1 P07099 1/20 0.41
MAPT P10636 3/20 0.41
HSD17B10 Q99714 2/20 0.41
ESR2 Q92731 1/20 0.41
ALDH1A1 P00352 3/20 0.40
MEN1 O00255 2/20 0.40
KMT2A Q03164 2/20 0.40
TP53 P04637 1/20 0.40
ALOX15 P16050 1/20 0.40
MAPK1 P28482 1/20 0.40
BRCA1 P38398 1/20 0.40
HBB P68871 1/20 0.40
RXFP1 Q9HBX9 1/20 0.40
POLB P06746 1/20 0.40
HTT P42858 1/20 0.40
CA12 O43570 1/20 0.39
CA1 P00915 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7013645 0.86 HIF1A (0.49) KDM4ENQO1TSHRMAPTHSD17B10
SCHEMBL29657372 0.82 NQO1 (0.59) KDM4ENQO1TSHREPHX1MAPT
SCHEMBL2498271 0.82 NQO1 (0.59) KDM4ENQO1TSHREPHX1MAPT
SCHEMBL9488121 0.79 NQO1 (0.54) KDM4ENQO1TSHREPHX1MAPT
SCHEMBL19612211 0.77 KDM4E (0.61) KDM4ENQO1TSHRMAPTKMT2A
SCHEMBL2096019 0.77 L3MBTL1 (0.53) MAPTALDH1A1ALOX15CYP1A2
SCHEMBL2096166 0.77 NQO1 (0.64) KDM4ENQO1TSHRALDH1A1MEN1
SCHEMBL7273575 0.76 KDM4E (0.51) KDM4ENQO1TSHREPHX1MAPT
SCHEMBL16061418 0.76 KDM4E (0.47) KDM4ENQO1TSHREPHX1MAPT
SCHEMBL9098166 0.76 CA12 (0.42) KDM4EMAPTHSD17B10ALDH1A1MEN1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20120282549-A1 PHOTOSENSITIVE COMPOSITION, PHOTOSENSITIVE FILM, PHOTOSENSITIVE LAMINATE, METHOD FOR FORMING PERMANENT PATTERN, AND PRINTED BOARD FUJIFILM CORPORATION (JP) 2012-11-08 US disclosed
US-20110123929-A1 OXIME COMPOUND, PHOTOSENSITIVE COMPOSITION, COLOR FILTER, PRODUCTION METHOD FOR THE COLOR FILTER, AND LIQUID CRYSTAL DISPLAY ELEMENT FUJIFILM CORPORATION (JP) 2011-05-26 US disclosed
EP-2116527-A1 OXIME COMPOUND, PHOTOSENSITIVE COMPOSITION, COLOR FILTER, METHOD FOR PRODUCTION OF THE COLOR FILTER, AND LIQUID CRYSTAL DISPLAY ELEMENT FUJIFILM Corporation (JP) 2009-11-11 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20110123929-A1 OXIME COMPOUND, PHOTOSENSITIVE COMPOSITION, COLOR FILTER, PRODUCTION METHOD FOR THE COLOR FILTER, AND LIQUID CRYSTAL DISPLAY ELEMENT PPOX, CRY2, HCCS KDM4E 114/4885NQO1 3671/4885TSHR 964/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.